[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"conditionNormalized\":\"chronic-dissection\",\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:chronic-dissection":31},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":10,"hasResults":11,"nctId":12,"briefTitle":13,"officialTitle":14,"acronym":15,"eligibilityCriteria":16,"healthyVolunteers":11,"sex":17,"minAge":18,"maxAge":4,"enrollmentInfo":19,"targetDuration":22,"studyType":23,"phases":4,"briefSummary":24,"conditions":25,"keywords":32,"overallStatus":40,"whyStopped":4,"lastUpdateSubmitDate":41,"lastUpdatePostDateStruct":42,"startDateStruct":45,"completionDateStruct":47,"leadSponsor":49,"locationsCount":4},"100629878","real-world-data-collection-of-gore-devices-used-in-the-endovascular-treatment-of-aortic-aneurysms-which-incorporate-visceral-arteries-100629878",false,"NCT07480395","Real-World Data Collection of GORE Devices Used In the Endovascular Treatment of Aortic Aneurysms Which Incorporate Visceral Arteries.","The ENVISION Registry: REal-World Data CollectioN of GORE deVIceS Used In the endOvascular treatmeNt of Aortic Aneurysms Which Incorporate Visceral Arteries.","ENVISION","Inclusion Criteria:\n\n1. Informed Consent Form (ICF) is signed by Subject.\n2. Age ≥ 18 years at time of informed consent signature.\n3. Patient presents with thoracoabdominal, pararenal, juxtarenal, or short-neck infrarenal aortic pathology suitable for endovascular repair.\n4. Patient requires the incorporation of ≥ 1 visceral artery and is suitable for use of at least 1 GORE® VIABAHN® VBX Balloon Expandable Endoprosthesis (BXB) as a bridging stent (Note: Up to six (6) visceral arteries may be incorporated).\n5. Patient is willing to adhere to the institutional standard of care follow-up.\n\nExclusion Criteria:\n\n1. Patient has a prior visceral artery stenting not associated with registry procedure.\n2. Patient treated for acute or sub-acute dissection, \\\u003C90 days from onset of symptoms\n3. Patient is intended to be treated with a parallel grafting (e.g., chimney, periscope, sandwich) or octopus technique.\n4. Known hypersensitivity to heparin or a previous incident of Heparin-Induced Thrombocytopenia (HIT) type II.\n5. Patient has known coagulation disorders including hypercoagulability that are not amenable to treatment.\n6. Patient has a life expectancy \\\u003C 1-year.\n7. Patient is participating in an investigational study which may confound registry results, unless approved by Gore","ALL","18 Years",{"count":20,"type":21},400,"ESTIMATED","5 Years","OBSERVATIONAL","The registry population consists of patients presenting with complex aortic pathologies amenable to endovascular aortic repair that requires the incorporation of bridging stents to maintain visceral artery perfusion",[26,27,28,29,30,31],"Complex Aortic Aneurysms","Thoracoabdominal Aneurysm","Fenestrated Endovascular Aortic Repair","Endovascular Aortic Repair","Abdominal Aorta Aneurism","Chronic Dissection",[33,34,35,36,37,38,39],"FEVAR","BEVAR","TAAA","AAA","Visceral","aortic aneurysm","PMEGs","NOT_YET_RECRUITING","2026-05-27",{"date":43,"type":44},"2026-06-01","ACTUAL",{"date":46,"type":21},"2026-12",{"date":48,"type":21},"2035-12",{"name":50,"class":51},"W.L.Gore & Associates","INDUSTRY"]